Radiopharm Theranostics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 10, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Market Cap	78	37	-	-	-
Market Cap Growth	39.20%	-	-	-	-
Enterprise Value	41.62	8.96	0	0	0
PS Ratio	4.79	10.07	-	-	-
PB Ratio	1.56	0.82	-	-	-
P/TBV Ratio	0.00	0.72	-	-	-
P/FCF Ratio	-	-1.00	-	-	-
P/OCF Ratio	-	-1.00	-	-	-
EV/Sales Ratio	2.56	2.47	-	-	-
EV/EBITDA Ratio	-	-0.23	-	-	-
EV/EBIT Ratio	-	-0.23	-	-	-
EV/FCF Ratio	-	-0.24	-	-	-
Debt / Equity Ratio	0.06	0.08	0.23	0.17	-
Debt / EBITDA Ratio	-0.06	-0.09	-0.13	-0.23	-
Debt / FCF Ratio	-0.04	-0.09	-0.28	-0.34	-
Net Debt / Equity Ratio	-0.61	-0.57	-0.44	-0.09	-
Net Debt / EBITDA Ratio	0.68	0.67	0.26	0.11	-
Net Debt / FCF Ratio	0.43	0.70	0.53	0.17	-
Asset Turnover	0.04	0.05	0.00	0.01	-
Quick Ratio	3.00	2.65	1.11	1.22	-
Current Ratio	3.01	2.67	1.30	1.23	-
Return on Equity (ROE)	-147.51%	-109.20%	-131.49%	-151.87%	-
Return on Assets (ROA)	-50.99%	-48.29%	-64.37%	-92.13%	-
Return on Invested Capital (ROIC)	-99.99%	-85.27%	-94.57%	-119.38%	-
Return on Capital Employed (ROCE)	-60.16%	-60.59%	-81.27%	-111.75%	-
FCF Yield	-	-100.18%	-	-	-
Buyback Yield / Dilution	-46.91%	-147.57%	-	-	-

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.